2020
Percutaneous Ablation of Intrathoracic Malignancy
Thakore S, Perez Lozada J. Percutaneous Ablation of Intrathoracic Malignancy. Current Pulmonology Reports 2020, 9: 171-180. DOI: 10.1007/s13665-020-00262-y.Peer-Reviewed Original ResearchStereotactic body radiotherapyPercutaneous ablationImage-guided percutaneous ablationNumber one cancer killerDifferent side effect profilesComparable overall survivalPost-ablation complicationsEarly-stage diseaseSide effect profilePercutaneous ablative therapiesPalliative intentReviewLung cancerMost patientsOverall survivalSublobar resectionSurgical resectionThoracic malignanciesClinical outcomesEffect profileIntrathoracic malignanciesAblative therapyBody radiotherapyLung cancerRadiofrequency ablationAblative techniques
2018
Locoregional Therapies in the Management of Hepatocellular Carcinoma
Levey A, Ermentrout R, Bercu Z, Kies D. Locoregional Therapies in the Management of Hepatocellular Carcinoma. 2018, 57-72. DOI: 10.1007/978-3-319-91977-5_5.Peer-Reviewed Original ResearchHepatocellular carcinomaLocoregional therapyLiver functionConcomitant chronic liver diseaseImage-guided percutaneous ablationLiver diseaseManagement of hepatocellular carcinomaPatient's liver functionPrimary liver malignancyDevelopment of hepatocellular carcinomaIntrinsic liver diseaseManagement of patientsCancer-related deathsChronic liver diseaseUnresectable diseasePercutaneous ablationPerformance statusRare causeLiver malignanciesBiliary cirrhosisViral hepatitisAlcoholic cirrhosisTreatment optionsTumor therapyPatients
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply